Cited by 571Glioma Diagnosis and TreatmentCancer-related Molecular PathwaysChromatin Remodeling and Cancer

The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.

Frequent Co‐Alterations of TP53, p16/CDKN2A, p14 ARF , PTEN Tumor Suppressor Genes in Human Glioma Cell Lines.

Open access

Ishii, Nobuaki, Maier, Daniel, Merlo, Adrian, Tada, Mitsuhiro, Sawamura, Yutaka, Diserens, Annie‐Claire, Van Meir, Erwin G.·1999·Brain Pathology

DOI 10.1111/j.1750-3639.1999.tb00536.xPMC PMC8098486

Open this paper in CoChat — free account

Abstract

In this study we established the simultaneous status of TP53, p16, p14ARF and PTEN tumor suppressor genes in 34 randomly chosen human glioma cell lines. Nine cell lines (26.4%) harbored mutations or deletions in all four tumor suppressor genes and 22 cell lines (64%) had alterations in at least three. Mutations/deletions were found at the following frequencies: TP53 (76.5%), p14ARF (64.7%), p16 (64.7%), PTEN (73.5%). Thus, there was a high incidence of alterations in the cellular pathways involving the p53 transcription factor (94.1%), the retinoblastoma protein (64.7%) and the PTEN phosphatase (73.5%) and 91% of cell lines carried mutations in two or more pathways. This provides the first clear genetic evidence that these tumor suppressors participate in biological pathways which are functioning separately/independently in glioma cells. The status of the gene alterations did not correlate with tumorigenicity in immunocompromized mice or any clinical parameters. Although the mutation rate was higher in glioma cell lines than that reported for glioma tissues, the alterations were molecularly representative of those found in adult de novo glioblastoma. This study highlights the importance of developing therapeutic approaches applicable to tumors with a broad range of genetic alterations and also provides an invaluable panel of glioma cell lines to make this possible.

Integrity signals

Registry

Crossref · 10.1111/j.1750-3639.1999.tb00536.x

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,742
5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E. W., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,992
Self-citation
ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521
Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
Kamb, A., Shattuck-Eidens, D. M., Eeles, R. A., Liu, Q., Gruis, N. A., Ding, W., Hussey, C. E., Tran, T., Miki, Y., Weaver-Feldhaus, J., et al. (1994) · Nature Genetics · doi:10.1038/ng0994-22 · Cited by 855
P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase
Myers, M. P., Stolarov, J. P., Eng, C., Li, J., Wang, S. I., Wigler, M. H., Parsons, R. E., & Tonks, N. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9052 · Cited by 775

Show all 48 references

Research works printed but not linked: 1

KleihuesP CaveneeWK(1997).Pathology and Genetics of Tumors of the Nervous System.International Agency for Research on Cancer: 1st edition Lyon.

Sorted by citations

Items 101–200 of 571

Antiproliferative effect of quercetin in the human U138MG glioma cell line
Braganhol, E., Zamin, L. L., Cañedo, A. D., Horn, F., Tamajusuku, A. S. K., Wink, M. R., Salbego, C. G., & Battastini, A. M. O. (2006) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000215063.23932.02 · Cited by 107
Thrombospondin-1 Is Downregulated by Anoxia and Suppresses Tumorigenicity of Human Glioblastoma Cells
Tenan, M., Fulci, G., Albertoni, M., Diserens, A., Hamou, M., Atifi, M. E., Feige, J., Pepper, M. S., & Meir, E. G. V. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.10.1789 · Cited by 110
Self-citation
Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240
Fenton, T. R., Nathanson, D. A., de Albuquerque, C. P., Kuga, D., Iwanami, A., Dang, J. H. T., Yang, H., Tanaka, K., Oba‐Shinjo, S. M., Uno, M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211962109 · Cited by 106
Aberrant Methylation and Down-Regulation of TMS1/ASC in Human Glioblastoma
Stone, A. R., Bobo, W. V., Brat, D. J., Devi, N. S., Meir, E. G. V., & Vertino, P. M. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63376-7 · Cited by 107
Dishevelled 2 Signaling Promotes Self-Renewal and Tumorigenicity in Human Gliomas
Pulvirenti, T., van der Heijden, M., Droms, L. A., Huse, J. T., Tabar, V. S., & Hall, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1531 · Cited by 103
HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression
Kessler, J., Hahnel, A., Wichmann, H., Rot, S., Kappler, M., Bache, M., & Vordermark, D. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-605 · Cited by 103
Brain Angiogenesis Inhibitor 1 Is Differentially Expressed in Normal Brain and Glioblastoma Independently of p53 Expression
Kaur, B., Brat, D. J., Calkins, C. C., & Meir, E. G. V. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63794-7 · Cited by 102
Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteins
Ziegler, D. S., Wright, R. D., Kesari, S., Lemieux, M. E., Tran, M. A., Jain, M., Zawel, L. S., & Kung, A. L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34120 · Cited by 100
Molecular determinants of glioma cell migration and invasion
Wild-Bode, C., Weller, M., & Wick, W. (2001) · Journal of Neurosurgery · doi:10.3171/jns.2001.94.6.0978 · Cited by 130
Mesenchymal stem cell signaling in cancer progression
Torsvik, A., & Bjerkvig, R. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.03.005 · Cited by 100
Human Brat Ortholog TRIM3 Is a Tumor Suppressor That Regulates Asymmetric Cell Division in Glioblastoma
Chen, G., Kong, J., Tucker‐Burden, C., Anand, M., Rong, Y., Rahman, F., Moreno, C. S., Meir, E. G. V., Hadjipanayis, C. G., & Brat, D. J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3703 · Cited by 100
Induction of Nonapoptotic Cell Death by Activated Ras Requires Inverse Regulation of Rac1 and Arf6
Bhanot, H., Young, A. M., Overmeyer, J. H., & Maltese, W. A. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0090 · Cited by 101
PIK3CA alterations in primary (de novo) and secondary glioblastomas
Kita, D., Yonekawa, Y., Weller, M., & Ohgaki, H. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0186-1 · Cited by 100
TP53 promoter methylation in human gliomas
Amatya, V. J., Naumann, U., Weller, M., & Ohgaki, H. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1041-5 · Cited by 102
Genetic and Biologic Progression in Astrocytomas and Their Relation to Angiogenic Dysregulation
Brat, D. J., Castellano-Sanchez, A. A., Kaur, B., & Meir, E. G. V. (2002) · Advances in Anatomic Pathology · doi:10.1097/00125480-200201000-00004 · Cited by 96
Loss of focal adhesion kinase (FAK) inhibits epidermal growth factor receptor-dependent migration and induces aggregation of nh(2)-terminal FAK in the nuclei of apoptotic glioblastoma cells.
Jones, G., Machado, J., & Merlo, A. U. (2001) · PubMed · Cited by 96
Self-citation
PTEN has tumor-promoting properties in the setting of gain-of-function p53 mutations
Li, Y., Guessous, F., Kwon, S., Kumar, M., Ibidapo, O., Fuller, L., Johnson, E., Lal, B., Hussaini, I., Bao, Y., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1963 · Cited by 95
Oncoprotein Bmi-1 Renders Apoptotic Resistance to Glioma Cells through Activation of the IKK-Nuclear Factor-κB Pathway
Li, J., Gong, L.-Y., Song, L.-B., Jiang, L.-L., Liu, L.-P., Wu, J., Yuan, J., Cai, J.-C., He, M., Wang, L., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090502 · Cited by 84
PAX6 Suppresses the Invasiveness of Glioblastoma Cells and the Expression of the Matrix Metalloproteinase-2 Gene
Mayes, D. A., Hu, Y., Teng, Y., Siegel, E. R., Wu, X., Panda, K. M., Tan, F., Yung, W. K. A., & Zhou, Y.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3877 · Cited by 94
Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro
Maurer, G. D., Tritschler, I., Adams, B., Tabatabai, G., Wick, W., Stupp, R., & Weller, M. (2009) · Neuro-Oncology · doi:10.1215/15228517-2009-012 · Cited by 93
SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans
Liu, K.-W., Feng, H., Bachoo, R. M., Kazlauskas, A., Smith, E. M., Symes, K., Hamilton, R. L., Nagane, M., Nishikawa, R., Hu, B., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43690 · Cited by 92
Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma
Yin, S., Girnita, A., Strömberg, T., Khan, Z., Andersson, S., Zheng, H., Ericsson, C., Axelson, M., Nistér, M., Larsson, O. S., et al. (2009) · Neuro-Oncology · doi:10.1093/neuonc/nop008 · Cited by 92
A proprotein convertase/MMP-14 proteolytic cascade releases a novel 40 kDa vasculostatin from tumor suppressor BAI1
Cork, S. M., Kaur, B., Devi, N. S., Cooper, L., Saltz, J. H., Sandberg, E. M., Kaluz, Š., & Meir, E. G. V. (2012) · Oncogene · doi:10.1038/onc.2012.1 · Cited by 91
PAX6 suppresses growth of human glioblastoma cells
Zhou, Y.-H., Wu, X., Tan, F., Shi, Y.-X., Glass, T. L., Liu, T. J., Wathen, K., Hess, K. R., Gumin, J., Lang, F. F., et al. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-1720-4 · Cited by 91
New drugs are not enough‑drug repositioning in oncology: An update
Armando, R., Mengual G�mez, D., & Gomez, D. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.4966 · Cited by 90
PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas
Nakamura, J. L., Karlsson, A., Arvold, N. D., GOTTSCHALK, A. R., Pieper, R. O., Stokoe, D., & Haas-Kogan, D. A. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-1718-y · Cited by 90
Ezrin-Dependent Promotion of Glioma Cell Clonogenicity, Motility, and Invasion Mediated by BCL-2 and Transforming Growth Factor-β2
Wick, W., Grimmel, C., Wild‐Bode, C., Platten, M., Arpin, M., & Weller, M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-10-03360.2001 · Cited by 90
ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARα -mediated inhibition of Glioma cell motility in vitro
Drukała, J., Urbańska, K., Wilk, A. M., Grabacka, M., Wybieralska, E., Valle, L. D., Madeja, Z., & Reiss, K. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-159 · Cited by 90
Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma
Bušek, P., Balážiová, E., Matrasová, I., Hilser, M., Tomáš, R., Syrůček, M., Zemanová, Z., Krepela, E., Běláček, J., & Šedo, A. (2016) · Tumor Biology · doi:10.1007/s13277-016-5274-9 · Cited by 88
Lactate dehydrogenase-A inhibition induces human glioblastoma multiforme stem cell differentiation and death
Daniele, S., Giacomelli, C., Zappelli, E., Granchi, C., Trincavelli, M. L., Minutolo, F., & Martini, C. (2015) · Scientific Reports · doi:10.1038/srep15556 · Cited by 86
miR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas
Haemmig, S., Baumgartner, U., Glück, A., Zbinden, S., Tschan, M. P., Каппелер, А., Mariani, L., Vajtai, I., & Vassella, E. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.245 · Cited by 90
Extracellular NAD+ enhances PARP-dependent DNA repair capacity independently of CD73 activity
Wilk, A. M., Hayat, F., Cunningham, R., Li, J., Garavaglia, S., Zamani, L., Ferraris, D. M., Sýkora, P., Andrews, J., Clark, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-57506-9 · Cited by 91
Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
Fuxe, J., Akusjärvi, G., Goike, H. M., Roos, G., Collins, V. P., & Pettersson, R. F. (2000) · PubMed · Cited by 86
Flavopiridol induces apoptosis in glioma cell lines independent of retinoblastoma and p53 tumor suppressor pathway alterations by a caspase-independent pathway.
Alonso, M., Tamasdan, C., Miller, D. C., & Newcomb, E. W. (2003) · PubMed · Cited by 87
α-Actinin 1 and α-actinin 4: Contrasting roles in the survival, motility, and RhoA signaling of astrocytoma cells
Quick, Q., & Skalli, O. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.011 · Cited by 86
Calcium-Activated Potassium Channels BK and IK1 Are Functionally Expressed in Human Gliomas but Do Not Regulate Cell Proliferation
Abdullaev, I. F., Rudkouskaya, A., Mongin, A. A., & Kuo, Y.-H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012304 · Cited by 85
Untitled work
(2002) · PubMed · Cited by 85
Changes in Tumor Metabolism as Readout for Mammalian Target of Rapamycin Kinase Inhibition by Rapamycin in Glioblastoma
Liu, W., Su, H. C., Hildebrandt, I. J., Phelps, M. E., Czernin, J. G., & Weber, W. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1824 · Cited by 82
Altered molecular pathways in gliomas: An overview of clinically relevant issues
Rao, R. D., & James, C. D. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.07.002 · Cited by 83
Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment
Hong, S., You, J. Y., Paek, K., Park, J., Kang, S. J., Han, E. H., Choi, N., Chung, S. H., Rhee, W. J., & Kim, J. A. (2021) · Theranostics · doi:10.7150/thno.60851 · Cited by 83
Sui generis: gene therapy and delivery systems for the treatment of glioblastoma
KANE, J. R., Miska, J. M., Young, J. S., Kanojia, D., Kim, J. W., & Lesniak, M. S. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou355 · Cited by 82
Glioma an overview of current classifications characteristics molecular biology and target therapies
Gao, L. (2015) · Frontiers in bioscience · doi:10.2741/4362 · Cited by 82
Autophagy and oxidative stress in gliomas with IDH1 mutations
Gilbert, M. R., Liu, Y., Neltner, J. H., Pu, H., Morris, A. J., Sunkara, M., Pittman, T. A., Kyprianou, N., & Horbinski, C. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1194-6 · Cited by 78
EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180
Feng, H., Hu, B., Vuori, K., Sarkaria, J. N., Furnari, F. B., Cavenee, W. K., & Cheng, S.-Y. (2013) · Oncogene · doi:10.1038/onc.2013.198 · Cited by 82
Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme
Wang, Y., Moncayo, G. E., Morin, P., Xue, G., Grzmil, M., Lino, M. M., Clément‐Schatlo, V., Frank, S., Merlo, A. U., & Hemmings, B. A. (2012) · Oncogene · doi:10.1038/onc.2012.104 · Cited by 79
Self-citation
O6-Methylguanine-DNA Methyltransferase Regulation by p53 in Astrocytic Cells
Blough, M. D., Ƶlatescu, M. C., & Cairncross, J. G. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2782 · Cited by 77
The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair
Westhoff, M., Kandenwein, J. A., Karl, S., Vellanki, S. H., Braun, V., Eramo, A., Antoniadis, G., Debatin, K., & Fulda, S. (2009) · Oncogene · doi:10.1038/onc.2009.215 · Cited by 78
Arylsulfonamide KCN1 Inhibits In Vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP
Yin, S., Kaluz, Š., Devi, N. S., Jabbar, A. A., de Noronha, R. G., Mun, J.-Y., Zhang, Z., Boreddy, P. R., Wang, W., Wang, Z., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0861 · Cited by 78
Integrin α5β1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma
Renner, G., Janoušková, H., Noulet, F., Koenig, V., Guérin, É., Bär, S., Nüesch, J. P. F., Rechenmacher, F., Neubauer, S., Kessler, H., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.131 · Cited by 80
Plasmonic gold nanostar-mediated photothermal immunotherapy for brain tumor ablation and immunologic memory
Liu, Y., Chongsathidkiet, P., Crawford, B. M., Odion, R., Dechant, C. A., Kemeny, H. R., Cui, X., Maccarini, P. F., Lascola, C. D., Fecci, P. E., et al. (2019) · Immunotherapy · doi:10.2217/imt-2019-0023 · Cited by 77
Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines
Combs, S. E., Bohl, J., Elsässer, T., Weber, K., Schulz–Ertner, D., Debus, J., & Weyrather, W. K. (2009) · International Journal of Radiation Biology · doi:10.1080/09553000802641151 · Cited by 75
Bioenergetic Metabolites Regulate Base Excision Repair–Dependent Cell Death in Response to DNA Damage
Tang, J.-B., Goellner, E. M., Wang, X.-H., Trivedi, R. N., Croix, C. M. S., Jelezcova, E., Svilar, D., Brown, A. R., & Sobol, R. W. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0411 · Cited by 75
Longitudinal Expression Analysis of αv Integrins in Human Gliomas Reveals Upregulation of Integrin αvβ3 as a Negative Prognostic Factor
Schittenhelm, J., Schwab, E. I., Sperveslage, J., Tatagiba, M. S., Meyermann, R., Fend, F., Goodman, S. L., & Sipos, B. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182851019 · Cited by 73
Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data
Vastrad, B. M., Vastrad, C. M., Godavarthi, A., & Hariharapura, R. C. (2017) · Medical Oncology · doi:10.1007/s12032-017-1043-x · Cited by 72
PTEN Increases Autophagy and Inhibits the Ubiquitin-Proteasome Pathway in Glioma Cells Independently of its Lipid Phosphatase Activity
Errafiy, R., Aguado, C., Ghislat, G., Esteve, J. M., Gil, A., Loutfi, M., & Knecht, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083318 · Cited by 73
Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1α expression in human glioma cells by a proteasome-independent pathway: Implications for in vivo therapy
Newcomb, E. W., Ali, M., Schnee, T., Li, L., Lukyanov, Y., Fowkes, M. E., Miller, D. C., & Zagzag, D. (2005) · Neuro-Oncology · doi:10.1215/s1152851704000997 · Cited by 72
The development of necrosis and apoptosis in glioma: experimental findings using spheroid culture systems*
Bell, H. S., Whittle, I. R., Walker, M., LEAVER, H. A., & Wharton, S. B. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2001.00319.x · Cited by 71
Microarray Analysis of Temporal Gene Responses to Ionizing Radiation in Two Glioblastoma Cell Lines: Up-regulation of DNA Repair Genes
OTOMO, T., Hishii, M., Arai, H., Sato, K., & SASAI, K. (2004) · Journal of Radiation Research · doi:10.1269/jrr.45.53 · Cited by 71
NF-κB Is Required for Smac Mimetic-Mediated Sensitization of Glioblastoma Cells for γ-Irradiation–Induced Apoptosis
Berger, R. S., Jennewein, C., Marschall, V., Karl, S., Cristofanon, S., Wagner, L., Vellanki, S. H., Hehlgans, S., Rödel, F., Debatin, K., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0218 · Cited by 71
TRAIL Triggers Apoptosis in Human Malignant Glioma Cells Through Extrinsic and Intrinsic Pathways
Song, J. H., Song, D. K., Pyrzyńska, B., Petruk, K. C., Meir, E. G. V., & Hao, C. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00484.x · Cited by 71
Keep‐ING balance: Tumor suppression by epigenetic regulation
Tallen, G. R. N., & Riabowol, K. T. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.03.011 · Cited by 70
P14ARF inhibits human glioblastoma–induced angiogenesis by upregulating the expression of TIMP3
Zerrouqi, A., Pyrzynska, B., Febbraio, M., Brat, D. J., & Van Meir, E. G. (2012) · Journal of Clinical Investigation · doi:10.1172/jci38596 · Cited by 70
Oncolytic Activity of p53-Expressing Conditionally Replicative Adenovirus AdΔ24-p53 against Human Malignant Glioma
Geoerger, B., Vassal, G., Opolon, P., Dirven, C. M. F., Morizet, J., Laudani, L., Grill, J., Giaccone, G., Vandertop, W. P., Gerritsen, W. R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0499 · Cited by 70
Expression of podoplanin in human astrocytic brain tumors is controlled by the PI3K-AKT-AP-1 signaling pathway and promoter methylation
Peterziel, H., Muller, J., Danner, A., Barbus, S., Liu, H., Radlwimmer, B., Pietsch, T., Lichter, P., Schütz, G., Hess, J., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos055 · Cited by 68
Cold atmospheric plasma treatment of melanoma and glioblastoma cancer cells
Vermeylen, S., Waele, J. D., Vanuytsel, S., Backer, J. D., der Paal, J. V., Ramakers, M., Leyssens, K., Marcq, E., Audenaerde, J. R. M. V., Smits, E., et al. (2016) · Plasma Processes and Polymers · doi:10.1002/ppap.201600116 · Cited by 69
ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner
Brosnan‐Cashman, J. A., Yuan, M., Graham, M. K., Rizzo, A. J., Myers, K. M., Davis, C., Zhang, R., Esopi, D., Raabe, E. H., Eberhart, C. G., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204159 · Cited by 67
Death pathways triggered by activated Ras in cancer cells
Jean, H. O. (2010) · Frontiers in bioscience · doi:10.2741/3814 · Cited by 68
Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas
Shen, F., Zhang, Y., Yao, Y., Hua, W., Zhang, H.-S., Wu, J., Zhong, P., & Zhou, L. (2014) · Neurosurgical Review · doi:10.1007/s10143-014-0539-5 · Cited by 67
Genes and pathways driving glioblastomas in humans and murine disease models
Merlo, A. (2003) · Neurosurgical Review · doi:10.1007/s10143-003-0267-8 · Cited by 69
Self-citation
PTEN-independent induction of caspase-mediated cell death and reduced invasion by the focal adhesion targeting domain (FAT) in human astrocytic brain tumors which highly express focal adhesion kinase (FAK).
Jones, G., Machado, J., Tolnay, M., & Merlo, A. (2001) · PubMed · Cited by 65
Self-citation
DNA Hypermethylation Status of Multiple Genes in Prostate Adenocarcinomas
Konishi, N., Nakamura, M., Kishi, M., Nishimine, M., Ishida, E., & Shimada, K. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01318.x · Cited by 66
TIC10/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners in vitro and in vivo
Karpel‐Massler, G., Bâ, M., Shu, C., Halatsch, M., Westhoff, M., Bruce, J. N., Canoll, P., & Siegelin, M. D. (2015) · Oncotarget · doi:10.18632/oncotarget.5505 · Cited by 68
APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line
Montaldi, A. P., Godoy, P. R. D. V., & Sakamoto‐Hojo, E. T. (2015) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2015.06.001 · Cited by 66
The Polyamine Catabolic Enzyme SAT1 Modulates Tumorigenesis and Radiation Response in GBM
Brett-Morris, A., Wright, B. M., Seo, Y., Pasupuleti, V., Zhang, J., Lu, J., Spina, R., Bar, E. E., Gujrati, M. D., Schur, R. M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1249 · Cited by 66
Hypermethylation and Transcriptional Downregulation of the Carboxyl-Terminal Modulator Protein Gene in Glioblastomas
Knobbe-Thomsen, C. B., REIFENBERGER, J., Blaschke, B., & Reifenberger, G. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh064 · Cited by 66
Quantitative real-time PCR does not show selective targeting of p14ARF but concomitant inactivation of both p16INK4A and p14ARF in 105 human primary gliomas
Labuhn, M., Jones, G., Speel, E. M., Maier, D., Zweifel, C., Gratzl, O., Meir, E. G. V., Hegi, M. E., & Merlo, A. U. (2001) · Oncogene · doi:10.1038/sj.onc.1204197 · Cited by 66
Self-citation
Current Perspective on the Natural Compounds and Drug Delivery Techniques in Glioblastoma Multiforme
Behl, T., Sharma, A., Sharma, L. K., Sehgal, A., Singh, S., Sharma, N., Zengin, G., BUNGAU, S. G., Toma, M. M., Gîtea, D., et al. (2021) · Cancers · doi:10.3390/cancers13112765 · Cited by 67
Regulatory effect of nerve growth factor in 9 1 integrin-dependent progression of glioblastoma
Brown, M. C., Staniszewska, I., Lazarovici, P., Tuszynski, G. P., Valle, L. D., & Marcinkiewicz, C. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-0047 · Cited by 67
Different molecular patterns in glioblastoma multiforme subtypes upon recurrence
Martínez, R., Rohde, V., & Schackert, G. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9967-4 · Cited by 65
Differential SELEX in Human Glioma Cell Lines
Cerchia, L., Esposito, C. L., Jacobs, A. H., Tavitian, B., & de Franciscis, V. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007971 · Cited by 65
Retracted
A novel tumor-promoting role for nuclear factor IA in glioblastomas is mediated through negative regulation of p53, p21, and PAI1
Lee, J. S., Xiao, J., Patel, P., Schade, J., Wang, J., Deneen, B., Erdreich‐Epstein, A., & Song, H.-R. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not167 · Cited by 63
Glioma Survival Analysis Empowered With Data Engineering—A Survey
Wijethilake, N., Meedeniya, D., Chitraranjan, C. D., Perera, I., Islam, M., & Ren, H. (2021) · IEEE Access · doi:10.1109/access.2021.3065965 · Cited by 65
Stemness of the CT-2A Immunocompetent Mouse Brain Tumor Model: Characterization In Vitro
Binello, E., Qadeer, Z. A., Kothari, H. P., Emdad, L., & Germano, I. M. (2012) · Journal of Cancer · doi:10.7150/jca.4149 · Cited by 64
NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma
Wang, H., Pan, J., Luo, L., Ning, X., Ye, Z.-P., Yu, Z., & Li, W. (2015) · Molecular Cancer · doi:10.1186/1476-4598-14-2 · Cited by 64
Synergistic drug combinations for a precision medicine approach to interstitial glioblastoma therapy
Graham-Gurysh, E. G., Murthy, A. B., Moore, K. M., Hingtgen, S., Bachelder, E. M., & Ainslie, K. M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.028 · Cited by 63
IGF2BP3 promotes mRNA degradation through internal m7G modification
Liu, C., Dou, X., Zhao, Y., Zhang, L., Zhang, L., Dai, Q., Liu, J., Wu, T., Xiao, Y., & He, C. (2024) · Nature Communications · doi:10.1038/s41467-024-51634-w · Cited by 63
Therapeutic effects of the Sp1 inhibitor mithramycin A in glioblastoma
Seznec, J., Silkenstedt, B., & Naumann, U. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0266-x · Cited by 64
Loss of PTEN Binding Adapter Protein NHERF1 from Plasma Membrane in Glioblastoma Contributes to PTEN Inactivation
Molina, J. R., Morales, F. C., Hayashi, Y., Aldape, K., & Georgescu, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1271 · Cited by 63
Glioma cells on the run – the migratory transcriptome of 10 human glioma cell lines
Demuth, T., Rennert, J. L., Hoelzinger, D. B., Reavie, L. B., Nakada, M., Beaudry, C. E., Nakada, S., Anderson, E., Henrichs, A. N., McDonough, W. S., et al. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-54 · Cited by 63
The Synthetic Ligand of Peroxisome Proliferator-Activated Receptor-γ Ciglitazone Affects Human Glioblastoma Cell Lines
Straková, N., Ehrmann, J., Džubák, P., Bouchal, J., & Kolář, Z. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.063438 · Cited by 63
Expression of Eukaryotic Initiation Factor 5A and Hypusine Forming Enzymes in Glioblastoma Patient Samples: Implications for New Targeted Therapies
Preukschas, M., Hagel, C., Schulte, A., Riecken, K., Lamszus, K., Sievert, H., Pällmann, N., Bokemeyer, C., Hauber, J., Braig, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043468 · Cited by 61
MARCKS Regulates Growth and Radiation Sensitivity and Is a Novel Prognostic Factor for Glioma
Jarboe, J. S., Anderson, J. C., Duarte, C. W., Mehta, T. S., Nowsheen, S., Hicks, P. H., Whitley, A. C., Rohrbach, T. D., McCubrey, R. O., Chiu, S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3091 · Cited by 62
Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Cι-mediated attenuation of p38 MAP kinase signaling
Baldwin, R. M., Garratt-Lalonde, M., Parolin, D. A. E., Krzyzanowski, P. M., Andrade-Navarro, M. A., & Lorimer, I. A. J. (2005) · Oncogene · doi:10.1038/sj.onc.1209312 · Cited by 63
Late ROS accumulation and radiosensitivity in SOD1-overexpressing human glioma cells
Gao, Z., Sarsour, E. H., Kalen, A. L., Li, L., Kumar, M. G., & Goswami, P. C. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.08.009 · Cited by 61
Characterization and comparison of human glioblastoma models
Schulz, J., Rodgers, L. T., Kryscio, R. J., Hartz, A. M. S., & Bauer, B. (2022) · BMC Cancer · doi:10.1186/s12885-022-09910-9 · Cited by 59
GAPDH is not regulated in human glioblastoma under hypoxic conditions
Said, H. M., Hagemann, C., Stojic, J., Schömig, B., Vince, G. H., Flentje, M. P., Roosen, K., & Vordermark, D. (2007) · BMC Molecular Biology · doi:10.1186/1471-2199-8-55 · Cited by 60
Histone Deacetylase Inhibition and Blockade of the Glycolytic Pathway Synergistically Induce Glioblastoma Cell Death
Egler, V., Korur, S., Failly, M., Boulay, J., Imber, R., Lino, M. M., & Merlo, A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4182 · Cited by 59
Self-citation
Cancer Therapy with a Replicating Oncolytic Adenovirus Targeting the Hypoxic Microenvironment of Tumors
Post, D. E., Devi, N. S., Li, Z., Brat, D. J., Kaur, B., Nicholson, A. C., Olson, J. J., Zhang, Z., & Meir, E. G. V. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1432 · Cited by 64
Fermented Mistletoe Extract as a Multimodal Antitumoral Agent in Gliomas
Podlech, O., Harter, P. N., Mittelbronn, M. G. A., Pöschel, S., & Naumann, U. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/501796 · Cited by 60
Retracted
New Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent Cancer
Regina, G. L., Bai, R., Coluccia, A., Famiglini, V., Pelliccia, S., Passacantilli, S., Mazzoccoli, C., Ruggieri, V., Verrico, A., Miele, A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00310 · Cited by 60

Authors: Ishii, N., Maier, D., Merlo, A., Tada, M., Sawamura, Y., Diserens, A., & Van Meir, E. G.
Affiliations: Centre Hospitalier Universitaire Vaudois (CH)
University Hospital of Basel (CH)
Hokkaido University (JP)
ORCID: Ishii, Nobuaki
Tada, Mitsuhiro
Venue: Brain Pathology
Publisher: Wiley
Published: 1999-07
Volume: 9
Issue: 3
Pages: 469-479
ISSN: 1015-6305 (ISSN-L)
1750-3639
DOI: 10.1111/j.1750-3639.1999.tb00536.x
PMC: PMC8098486
OpenAlex: W2155140015
Cited by: 569
References: 48
Citations by year: 2026: 9 · 2025: 10 · 2024: 24 · 2023: 20 · 2022: 21 · 2021: 23 · 2020: 13 · 2019: 25 · 2018: 14 · 2017: 16 · 2016: 14 · 2015: 27 · 2014: 33 · 2013: 25 · 2012: 34
FWCI: 11.06
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 2470 d)
Locations: Brain Pathology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
IRIS (submittedVersion)
SERVAL (Université de Lausanne) (submittedVersion)
Topics: Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: glioma cell lines, TP53 mutation, CDKN2A/p16, p14ARF, PTEN, p53 pathway, glioblastoma, tumorigenicity, genetic alterations
MeSH terms: Adult, Aged, Animals, Brain Neoplasms, Child, DNA Mutational Analysis, Female, Glioma, Humans, Male, Mice, Nude, Middle Aged, Neoplasm Transplantation, Neoplastic Processes, Phosphoric Monoester Hydrolases, Proteins, Sex Factors, Tumor Cells, Cultured, Genes, Tumor Suppressor, Tumor Suppressor Protein p53, Point Mutation, Sequence Deletion, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Proteins, Tumor Suppressor Protein p14ARF, PTEN Phosphohydrolase, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Frequent Co‐Alterations of TP53, p16/CDKN2A, p14 ARF , PTEN Tumor Suppressor Genes in Human Glioma Cell Lines.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks